Business / Finance

RSS
Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

BioEcho Life Sciences enters the US diagnostic market with an FDA-listed product

BioEcho Life Sciences enters the US diagnostic market with an FDA-listed product

Ingenza and Phibro Ethanol accelerate the green fuel transition

Ingenza and Phibro Ethanol accelerate the green fuel transition

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries

Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

NanoSyrinx appoints Anthony Johnson as Non-Executive Director

NanoSyrinx appoints Anthony Johnson as Non-Executive Director

BioEcho introduces EchoLUTION™ FFPE RNA Kit for superior RNA extraction from FFPE tissues

BioEcho introduces EchoLUTION™ FFPE RNA Kit for superior RNA extraction from FFPE tissues

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Industry & academia combine to support synthesis of squaric acid monoamides as building blocks for drug discovery

Industry & academia combine to support synthesis of squaric acid monoamides as building blocks for drug discovery

CN Bio appoints Neil Rumbelow as Director of Product Development

CN Bio appoints Neil Rumbelow as Director of Product Development

PacBio announces HiFi Solves, a global consortium of clinical genomics research leaders

PacBio announces HiFi Solves, a global consortium of clinical genomics research leaders

Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

PacBio enables rare and inherited disease research by adding tertiary analysis partners to PacBio Compatible

PacBio enables rare and inherited disease research by adding tertiary analysis partners to PacBio Compatible

PacBio announces Kinnex RNA Kits, further scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA applications

PacBio announces Kinnex RNA Kits, further scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA applications

Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation

Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.